Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cancer Vaccines
Studies by A. Balamurugan and co-authors describe new findings in cancer vaccines
December 16th, 2008
Investigators publish new data in the report 'Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors.' "The recent licensure of human papillomavirus (HPV) vaccines will likely decrease the development of primary in situ and invasive cervical cancers and possibly other HPV-associated cancers such as vaginal, vulvar, and anal cancers. Because the HPV vaccine has the ability to impact the development of >1 HPV-associated cancer in the same individual, the risk of developing subsequent primary cancers among cervical cancer survivors was examined," scientists in the United States report. ...
Source: Cancer Weekly (2008-12-16)
|
